CIK 0001177648
- Non-accelerated filer
- Smaller reporting company
ENANTA PHARMACEUTICALS INC
Sign in to watch- Ticker
- ENTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Entity type
- Operating
- EIN
- 043205099
- Phone
- +1 617-607-0800
- Business address
- 4 KINGSBURY AVENUE, WATERTOWN, MA, 02472
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-14 | Luly Jay R. President and CEO | Shares withheld for taxes | −2,355 | $62.49 | $147K | 716,464 |
| 2022-01-15 | Luly Jay R. President and CEO | Option exercise | +10,063 | $11.77 | $118K | 710,791 |
| 2022-01-15 | Luly Jay R. President and CEO | Option exercise · Stock Option (right to buy) | −10,063 | 0 | ||
| 2022-01-11 | Adda Nathalie Sr. VP & Chief Medical Officer | Option exercise | +9,200 | $43.46 | $400K | 42,102 |
| 2022-01-11 | Adda Nathalie Sr. VP & Chief Medical Officer | Option exercise | +3,336 | $30.00 | $100K | 45,438 |
| 2022-01-11 | Adda Nathalie Sr. VP & Chief Medical Officer | Sale | −12,536 | $70.13 | $879K | 32,902 |
| 2022-01-11 | Adda Nathalie Sr. VP & Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −9,200 | 36,820 | ||
| 2022-01-11 | Adda Nathalie Sr. VP & Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −3,336 | 31,664 | ||
| 2021-12-01 | Gardiner Nathaniel S. Sr. VP & General Counsel | Shares withheld for taxes | −557 | $87.68 | $49K | 59,226 |
| 2021-12-01 | Adda Nathalie Sr. VP & Chief Medical Officer | Shares withheld for taxes | −842 | $87.68 | $74K | 32,902 |
| 2021-12-01 | Adda Nathalie Sr. VP & Chief Medical Officer | Option exercise | +8,750 | $43.46 | $380K | 41,652 |
| 2021-12-01 | Adda Nathalie Sr. VP & Chief Medical Officer | Option exercise | +4,773 | $48.52 | $232K | 46,425 |
| 2021-12-01 | Adda Nathalie Sr. VP & Chief Medical Officer | Sale | −1,587 | $84.81 | $135K | 44,838 |
| 2021-12-01 | Adda Nathalie Sr. VP & Chief Medical Officer | Sale | −5,736 | $85.49 | $490K | 39,102 |
| 2021-12-01 | Adda Nathalie Sr. VP & Chief Medical Officer | Sale | −2,700 | $86.45 | $233K | 36,402 |
| 2021-12-01 | Adda Nathalie Sr. VP & Chief Medical Officer | Sale | −1,500 | $87.60 | $131K | 34,902 |
| 2021-12-01 | Adda Nathalie Sr. VP & Chief Medical Officer | Sale | −900 | $88.31 | $79K | 34,002 |
| 2021-12-01 | Adda Nathalie Sr. VP & Chief Medical Officer | Sale | −899 | $89.33 | $80K | 33,103 |
| 2021-12-01 | Adda Nathalie Sr. VP & Chief Medical Officer | Sale | −201 | $90.17 | $18K | 32,902 |
| 2021-12-01 | Adda Nathalie Sr. VP & Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −8,750 | 46,020 |
Page 15 of 19 · 377 trades